Is the COVID-19 pandemic a wake-up call for value-based payment innovation and care delivery, or does it raise serious questions about value-based models’ ability to perform? Host Mark Moticik circles up with David Delaney, Cindy Garvin, and Andrei Gonzalez to explore the immediate and lasting impact of COVID-19 on value-based care, and review the steps payers can take to understand how alternative payment and care models performed throughout the crisis.
Today’s expert panel convened Mark Moticik, vice president of Payer BPaaS Services at Change Healthcare; David Delaney, MD, senior vice president and general manager of Payer Technology Enabled Services at Change Healthcare; Cindy Garvin, senior consulting manager at Change Healthcare; and Andrei Gonzalez, associate vice president, Product Management, Value-Based Payments at Change Healthcare.
Listen in for the panel’s insights on:
- How COVID-19 is influencing momentum around value-based care
- Whether the pandemic can accelerate the case for value-based care
- Potential changes to the relationship between primary care physicians and specialists
- New provider and payer perspectives on risk, capitation, and other alternative payment models
- Which innovations in care, such as telemedicine and drive-thru testing, will persist beyond the COVID-19 crisis
- How these innovations can impact the value equation long term
- Ways to create a more elastic healthcare system in the U.S.
- Why the healthcare industry’s experience fighting COVID-19 could change the definition of value-based care
- Predictions on how COVID-19 will impact the underlying economic model of care delivery
- Whether alternative payment models can co-exist with government-sponsored plans
- Latest lessons learned about social determinants of health (SDoH) beyond testing, treatments, and fatalities
- Steps payers can take to implement and sustain SDoH strategies